Budget Saving Potential of Pegfilgrastim Biosimilar for the Treatment of Chemotherapy-Induced Febrile Neutropenia, in Italy. (2022). Farmeconomia. Health Economics and Therapeutic Pathways, 23(1). https://doi.org/10.7175/fe.v23i1.1516